NAD+

What Is NAD+?

NAD+ stands for:

Nicotinamide Adenine Dinucleotide

It is a molecule found in essentially every living cell.

And first things first:

NAD+ is not a peptide.

We’re including it in the Peptide Library because NAD+ is commonly sold and discussed alongside peptides, longevity compounds, IV therapies, and research molecules.

Biologically, though, NAD+ belongs in a different category.

It is a coenzyme that cells depend on for some of their most fundamental functions.

Without adequate NAD+, cells couldn’t properly carry out many reactions involved in:

• Energy production
• Mitochondrial metabolism
• Glucose metabolism
• Fat metabolism
• DNA repair
• Cellular stress responses
• Gene regulation
• Calcium signaling

So unlike many compounds in the research market, there is no question about whether NAD+ is biologically important.

It absolutely is.

The unanswered question is whether deliberately increasing NAD+ produces meaningful anti-aging or therapeutic benefits in humans.

Why Are Researchers Interested in It?

NAD+ sits at the center of several biological systems that change with age.

Researchers have observed age-related alterations in NAD+ metabolism and have proposed that declining NAD+ availability may contribute to dysfunction involving:

mitochondria + DNA repair + inflammation + metabolism + cellular stress responses.

This generated a major research field sometimes referred to as:

NAD+ augmentation

or:

NAD+ boosting.

Strategies include giving NAD+ itself or providing molecules the body can use to manufacture NAD+, such as:

• Nicotinamide riboside — NR
• Nicotinamide mononucleotide — NMN
• Niacin
• Nicotinamide

Animal experiments have generated enormous excitement.

But more recent reviews emphasize that the human story is considerably less dramatic. A 2025 Nature Metabolismreview concluded that human clinical trials of NAD+ precursors have generally shown limited efficacy, and that evidence for a consistent age-related NAD+ decline across human tissues is less complete than is often implied online. 

How Does NAD+ Help Cells Produce Energy?

This is one of NAD+’s oldest and best-established roles.

NAD+ participates in redox reactions.

In simplified terms, NAD+ can accept electrons and become:

NADH

Then NADH can carry those electrons into processes involved in cellular energy production.

You can think of it like a reusable carrier:

NAD+ → accepts electrons → NADH → delivers electrons → becomes NAD+ again

This cycling is critical to:

glycolysis + the citric acid cycle + mitochondrial oxidative phosphorylation.

Ultimately, these processes help cells produce:

ATP

which is the molecule cells use as an immediate energy currency.

So NAD+ genuinely is connected to cellular energy.

But that doesn’t mean an NAD+ infusion functions like caffeine or instantly gives everyone more subjective energy.

NAD+ vs. NADH

These are two different chemical states of the same coenzyme system.

NAD+ is the oxidized form.

NADH is the reduced form after accepting electrons.

Cells continuously cycle between them.

The balance between NAD+ and NADH is important for metabolism and redox biology.

This is why discussions of NAD+ frequently include the:

NAD+/NADH ratio.

What About Mitochondria?

NAD+ is deeply involved in mitochondrial function.

Mitochondria use NADH-derived electrons during oxidative phosphorylation to help generate ATP.

NAD+ also supports enzymes involved in mitochondrial regulation and cellular stress responses.

That makes NAD+ central to research involving:

• Mitochondrial health
• Energy metabolism
• Metabolic aging
• Exercise
• Muscle function
• Oxidative stress

Animal research frequently shows improvements in metabolic and mitochondrial outcomes after NAD+-boosting interventions.

A 2026 systematic review identified 113 intervention studies, including 80 rodent studies and 33 human studies. Rodent studies frequently showed improvements in metabolic, mitochondrial, inflammatory, and functional outcomes—but human findings were much less consistent. 

That’s the recurring NAD+ story:

Really impressive mice. Much less dramatic humans.

What About Sirtuins?

This is where NAD+ entered mainstream longevity discussions.

Sirtuins are a family of enzymes involved in processes such as:

• Metabolic regulation
• Cellular stress responses
• DNA-related biology
• Mitochondrial function
• Gene expression

Sirtuins require NAD+ to function.

They consume NAD+ while carrying out enzymatic reactions.

This created the hypothesis that:

declining NAD+ → reduced sirtuin activity → age-related dysfunction

and therefore:

raising NAD+ → increased sirtuin activity → healthier aging.

This pathway has strong mechanistic and animal-model support.

But demonstrating that NAD+ supplementation meaningfully slows human aging is a much bigger challenge.

What About DNA Repair?

NAD+ also serves as a substrate for another group of enzymes called:

PARPs — poly(ADP-ribose) polymerases.

PARPs become active when cells detect DNA damage.

They consume NAD+ while participating in DNA-damage responses.

This creates an interesting biological relationship:

DNA damage increases → PARP activity increases → NAD+ consumption increases.

Because DNA damage accumulates with aging, researchers have proposed that increased NAD+ consumption may contribute to age-associated NAD+ depletion.

Recent reviews continue to identify PARPs, sirtuins, and CD38 as major consumers linking NAD+ metabolism to aging biology. 

What Is CD38?

CD38 is another important NAD+-consuming enzyme.

It plays roles in:

immune signaling + calcium signaling + NAD+ metabolism.

Research suggests CD38 expression can increase with age and inflammation.

That has led to the hypothesis:

aging/inflammation → increased CD38 → increased NAD+ breakdown → lower NAD+ availability.

CD38 has therefore become its own potential target in longevity research. 

Again, this is biologically fascinating.

It doesn’t yet mean blocking CD38 or raising NAD+ has been shown to extend healthy human lifespan.

Does NAD+ Decline With Age?

This claim is repeated constantly:

“NAD+ drops by 50% by middle age.”

The reality is messier.

Animal research clearly shows age-related changes in NAD+ metabolism.

Human studies also show age-associated differences in certain tissues and populations.

But a major 2025 review found that consistent age-related NAD+ decline has only been demonstrated in a limited number of human studies and emphasized that NAD+ metabolism differs between tissues. 

So the safest version is:

NAD+ metabolism appears to change with aging, and declines have been observed in some human tissues—but the idea of one universal predictable whole-body decline is oversimplified.

Does Increasing NAD+ Reverse Aging?

No evidence currently establishes that.

This is probably the biggest leap in NAD+ marketing.

Researchers can often:

raise NAD+ biomarkers.

That’s not the same as demonstrating:

slower biological aging + longer lifespan + reversal of age-related disease.

A 2026 systematic review found that NAD-related interventions can reliably affect NAD-related biomarkers, but evidence for actual anti-aging and wellness outcomes in humans remains inconsistent and incomplete. 

So:

NAD+ biology and aging → strongly connected.

NAD+ therapy reverses human aging → not established.

What About Longevity?

Animal studies are where most of the excitement originated.

Increasing NAD+ availability in rodents has produced improvements involving:

• Glucose metabolism
• Lipid metabolism
• Mitochondrial function
• Vascular function
• Exercise capacity
• Neurobiology
• Liver metabolism
• Other age-associated endpoints

Some animal models show improved healthspan.

But humans are not giant mice.

A 2023 Endocrine Reviews assessment described the animal evidence as promising while emphasizing that clinical pharmacology and therapeutic effects in humans remain incompletely understood. 

And the newer 2025/2026 literature remains cautious. 

There is currently no convincing evidence that NAD+ therapy extends human lifespan.

What About Energy & Fatigue?

This is probably the most common reason people encounter NAD+ IV clinics.

The marketing often sounds like:

“NAD+ restores cellular energy.”

Biologically, NAD+ is essential for cellular metabolism and ATP production.

That’s true.

The problem is turning that fact into:

“An NAD+ infusion gives healthy people more energy.”

Clinical evidence doesn’t currently establish reliable major improvements in ordinary fatigue or subjective energy from NAD+ therapy.

Fatigue can also arise from dozens of causes unrelated to NAD+ status.

So:

energy metabolism → absolutely legitimate research area.

proven energy infusion → much weaker evidence.

What About Brain Fog & Cognition?

NAD+ biology is relevant to neurons because the brain consumes enormous amounts of energy.

Researchers have consequently investigated NAD+-related strategies in:

• Cognitive aging
• Neurodegeneration
• Parkinson’s disease
• Alzheimer’s disease
• Brain metabolism
• Neuroinflammation

Small human studies of NAD+ precursors have generated interesting signals in some neurological contexts, but evidence is not strong enough to establish NAD+ therapy as a treatment for cognitive decline or “brain fog.” 

That makes these appropriate discovery terms—not established benefits.

What About Parkinson’s Disease?

NAD+-related compounds have attracted particular attention in Parkinson’s research because mitochondrial dysfunction and cellular-energy abnormalities are relevant to the disease.

Human trials of NAD+ precursors such as nicotinamide riboside have been conducted in Parkinson’s populations.

Early research has shown that NAD+ metabolism can be modified in these patients and has produced some interesting biological signals.

But NAD+ or NR isn’t an established disease-modifying treatment for Parkinson’s.

Larger trials are needed. 

What About Metabolism & Insulin Resistance?

Animal research is very strong here.

NAD+-raising interventions have improved:

glucose metabolism + insulin sensitivity + fatty liver + weight gain

in numerous rodent models. 

Human results have been considerably more variable.

Some studies of NAD+ precursors have reported modest metabolic or cardiovascular effects in specific groups, while others find little clinically meaningful change.

This makes:

metabolic health + insulin resistance + glucose regulation

legitimate areas of ongoing research.

It does not make NAD+ a proven diabetes or weight-loss therapy.

Does NAD+ Cause Weight Loss?

There is no strong evidence showing NAD+ itself is an effective weight-loss treatment.

Animal work often finds favorable effects on metabolism and body composition.

But human NAD+-boosting trials have not established the kind of meaningful weight loss seen with medications such as GLP-1 receptor agonists.

So:

metabolic research → yes.

fat-burning or weight-loss treatment → no.

What About Exercise & Muscle?

Because NAD+ participates in mitochondrial metabolism, researchers have investigated NAD+-boosting strategies in:

• Muscle function
• Physical performance
• Exercise capacity
• Aging muscle
• Recovery
• Mitochondrial adaptation

Some human trials of NMN or NR have produced interesting findings involving muscle metabolism or performance-related endpoints.

But results are inconsistent and often modest.

A 2025 clinical review concluded that while NAD+ precursors generally raise NAD-related metabolites, convincing broad benefits for human aging remain limited. 

What About Inflammation?

NAD+ metabolism interacts closely with the immune system.

CD38, sirtuins, PARPs, mitochondria, and cellular stress responses all connect NAD+ to inflammatory biology.

Animal models often show reductions in inflammatory markers after NAD+-raising interventions.

Human evidence is more preliminary.

So NAD+ may be important within inflammatory pathways, but it should not be marketed as a general anti-inflammatory cure.

NAD+ vs. NMN

These are not the same molecule.

NAD+ is the final coenzyme cells use.

NMN — nicotinamide mononucleotide is a precursor the body can convert into NAD+.

In simplified form:

NMN → NAD+

NMN has become popular because delivering a precursor may allow cells to manufacture NAD+ through their own biosynthetic pathways.

Human NMN trials have shown that supplementation can raise NAD-related metabolites and is generally tolerated over the short periods studied, but evidence for major anti-aging effects remains limited. 

NAD+ vs. NR

NR — nicotinamide riboside is another NAD+ precursor.

A simplified pathway is:

NR → NMN → NAD+

NR has a larger human research base than many longevity supplements and clearly can increase certain NAD-related metabolites.

But once again:

increasing NAD+ biomarkers is easier to prove than improving health outcomes.

Current reviews continue to emphasize this distinction. 

What About Oral NAD+ Itself?

Historically, researchers questioned whether orally consumed NAD+ itself could meaningfully reach intracellular compartments intact.

That’s why most human research focused on precursors such as NMN and NR.

Interestingly, a 2026 randomized Phase 0/1b trial tested a specially formulated oral NAD+ product in adults aged 45–75.

Researchers reported increased whole-blood intracellular NAD-related measures after five days, without an increase in plasma NAD+. 

That’s interesting new evidence.

But it was a short, small study of a particular proprietary formulation.

It doesn’t establish that ordinary oral NAD+ supplements have the same pharmacokinetics—or that increasing intracellular NAD+ improves aging outcomes.

What About NAD+ IV Therapy?

This is where the science and wellness marketplace diverge quite sharply.

NAD+ IV infusions are marketed for:

• Energy
• Brain fog
• Anti-aging
• Addiction recovery
• Athletic recovery
• Mental clarity
• Detoxification
• Chronic fatigue

However, direct high-quality clinical research on IV NAD+ itself remains sparse.

The 2026 systematic review found far more human evidence for NAD+ precursors than for parenteral NAD+ therapy and concluded that direct clinical evidence for the wellness claims surrounding NAD+ administration remains limited. 

So the popularity of NAD+ IV therapy is currently ahead of the strength of its clinical evidence.

What About Addiction & Withdrawal?

NAD+ IV therapy is heavily marketed at some addiction-treatment and wellness clinics for:

alcohol withdrawal + opioid withdrawal + cravings + detox.

Historical reports exist, but modern high-quality randomized evidence is extremely limited.

There isn’t enough evidence to describe NAD+ IV as an established treatment for substance-use disorders or withdrawal.

Someone searching these topics should be able to find the profile.

But they should also see the evidence gap.

Is NAD+ a “Detox”?

Not in the vague wellness sense.

NAD+ is involved in cellular metabolism, redox reactions, and enzymes participating in stress and DNA-repair pathways.

Those are real biological processes.

But there isn’t evidence that NAD+ IV therapy broadly:

flushes toxins + cleanses the liver + resets the body.

“Detox” is doing a lot of marketing work there.

Could Too Much NAD+ Ever Be Bad?

Possibly.

This is a really interesting part of current research.

NAD+ is required by healthy cells.

But cancer cells also require energy, metabolism, DNA repair, and stress-response systems.

A 2026 review specifically highlighted NAD+’s context-dependent role in oncology, noting that NAD+ biology can potentially support malignant adaptation under some circumstances. 

Another very recent review emphasized that NAD+ effects on tissue repair may vary depending on cell type, tissue, timing, fibrosis, and cancer context. 

That doesn’t mean NAD+ causes cancer.

It means the simplistic idea:

“NAD+ is good, therefore more NAD+ is always better”

doesn’t fit the biology.

Evidence Snapshot

Basic Human Biology: Extremely strong
Cellular Energy Role: Extremely strong
Redox Biology: Extremely strong
DNA-Repair Pathway Involvement: Strong
Sirtuin Biology: Strong
Animal Aging Research: Extensive
Human NAD+ Precursor Trials: Yes
Human NMN/NR Biomarker Effects: Yes
Human Anti-Aging Outcomes: Limited/inconsistent
Direct NAD+ Human Trials: Limited
IV NAD+ Wellness Evidence: Very limited
Evidence for Human Lifespan Extension: No
Weight-Loss Evidence: Insufficient
FDA-Approved Anti-Aging Treatment: No
Overall Evidence: NAD+ is unquestionably essential biology; therapeutic NAD+ boosting is promising but has not produced convincing broad anti-aging benefits in humans. 

What Do We Know?

We know NAD+ is indispensable to cellular life.

It participates directly in:

energy metabolism → redox reactions → DNA repair → sirtuin activity → cellular signaling.

We also know that NAD+ metabolism changes with aging and disease, although the exact patterns differ across human tissues. 

And human trials demonstrate that compounds such as NR and NMN can raise NAD-related biomarkers.

Those are solid findings.

What Don’t We Know?

We don’t have strong evidence demonstrating that NAD+ therapy:

• Reverses aging
• Extends human lifespan
• Makes someone biologically younger
• Prevents dementia
• Treats Alzheimer’s disease
• Treats Parkinson’s disease
• Cures chronic fatigue
• Eliminates brain fog
• Produces major weight loss
• Treats insulin resistance reliably
• Builds muscle
• Dramatically improves athletic performance
• “Detoxes” the body
• Treats addiction or withdrawal
• Prevents cancer
• Improves every age-related condition
• Works better as an IV than less invasive NAD+-raising strategies

The difference between improving an NAD+ biomarker and improving a person’s health is one of the biggest unresolved questions in the field.

What About Safety?

Short-term human trials of NAD+ precursors such as NR and NMN have generally reported acceptable tolerability.

But several questions remain:

long-term exposure + ideal target levels + tissue-specific effects + interactions with disease + effects in cancer biology.

Direct IV NAD+ has a much thinner controlled safety database.

Injection and infusion also introduce issues unrelated to NAD+ biology itself, such as:

• Sterility
• Compounding quality
• Contamination
• Infusion reactions
• Product concentration

So safety data from an oral NR study can’t simply be transferred to an IV NAD+ product.

Research & Regulatory Status

NAD is currently listed by FDA among bulk drug substances nominated for use in compounding under Section 503A and still under evaluation. FDA’s May 14, 2026 list includes both nicotinamide adenine dinucleotide and reduced NADH in Category 1. 

That’s an important distinction:

Category 1 does not mean FDA approved.

It means the substance has been nominated for compounding and is still undergoing evaluation within that framework.

There is no FDA-approved NAD+ drug for general:

anti-aging + energy enhancement + brain fog + weight loss + wellness + addiction detox.

Your Pep Resource Takeaway

NAD+ is one of those topics where both sides of the internet tend to oversimplify it.

Calling it snake oil misses an enormous amount of real science.

NAD+ is genuinely essential to:

mitochondria + energy metabolism + DNA repair + sirtuins + cellular signaling.

But calling NAD+ therapy a proven way to:

reverse aging + restore energy + clear brain fog + detox the body + extend lifespan

goes way beyond the evidence.

The strongest human finding so far is much less flashy:

We can manipulate NAD+ metabolism in humans.

NR, NMN, and some newer NAD+ formulations can increase NAD-related biomarkers. 

What scientists are still trying to determine is whether that translates into meaningful improvements in:

healthspan + disease + physical function + cognition + longevity.

And as of 2026, the answer is:

sometimes there are interesting signals—but not the sweeping anti-aging transformation the marketing implies.

Research Areas / Search Keywords

NAD+, NAD, nicotinamide adenine dinucleotide, NAD plus, NAD therapy, NAD supplementation, NAD injection, NAD infusion, NAD IV, IV NAD, NAD drip, NAD wellness, NAD anti-aging, NAD longevity, NAD booster, NAD boosting, NAD metabolism, NAD levels, low NAD, cellular energy, cell energy, ATP, ATP production, mitochondria, mitochondrial health, mitochondrial function, mitochondrial dysfunction, cellular metabolism, energy metabolism, redox, redox balance, NADH, NAD+/NADH ratio, oxidative phosphorylation, glycolysis, citric acid cycle, Krebs cycle, electron transport chain, metabolism, metabolic health, aging, healthy aging, anti-aging research, longevity research, lifespan research, healthspan, biological aging, cellular aging, age-related decline, geroscience, sirtuins, SIRT1, SIRT3, sirtuin activation, PARP, PARP enzymes, DNA repair, DNA damage, genomic stability, CD38, NADase, cellular stress response, oxidative stress, free radicals, inflammation, chronic inflammation, inflammaging, tissue repair, cellular repair, fibrosis research, mitochondria and aging, brain health, brain energy, cognition, cognitive health, cognitive decline, brain fog, memory research, mental clarity, neurological health, neurodegeneration, Alzheimer’s research, dementia research, Parkinson’s research, neuroinflammation, fatigue, chronic fatigue research, low energy, energy boost research, exercise research, exercise performance, athletic performance, workout recovery, muscle health, muscle aging, sarcopenia research, metabolic syndrome, insulin resistance research, insulin sensitivity, glucose metabolism, blood sugar research, diabetes research, obesity research, weight loss research, fat metabolism, fatty liver research, liver health, cardiovascular health, vascular health, blood pressure research, addiction research, alcohol withdrawal research, opioid withdrawal research, detox research, NAD detox, wellness IV, anti-aging IV, NMN, nicotinamide mononucleotide, NMN supplement, NR, nicotinamide riboside, Niagen, niacin, nicotinamide, vitamin B3, NAD precursor, NAD precursors, NMN vs NAD, NR vs NAD, NMN vs NR, oral NAD, liposomal NAD, injectable NAD, IV NAD vs oral NAD, cancer metabolism research, tumor metabolism, cellular senescence, longevity molecules.

---

Educational Disclaimer: This profile is provided for educational and research-information purposes only. It is not medical advice and does not provide dosing, infusion protocols, anti-aging treatment, addiction treatment, or purchasing recommendations. NAD+ is an essential naturally occurring coenzyme, but evidence supporting supplemental or IV NAD+ for broad anti-aging and wellness claims remains limited. FDA currently lists NAD among nominated bulk substances under evaluation for pharmacy compounding; this does not constitute FDA approval.